A Phase 3 interventional study of Segmentectomy in Segmentectomy and Lung Adenocarcinoma, sponsored by Fudan University. Recruiting at 1 site in China. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2024-10-10.
Sponsored by Fudan University · Phase 3, Interventional, and Treatment
This is a clinical trial from Eastern Cooperative Thoracic Oncology Project (ECTOP), numbered as ECTOP-1025. The goal of this clinical trial is to confirm the theraputic effect of segmentectomy for solid-dominant invasive lung cancer with size of 2-3cm. The main questions it aims to answer are:
303 studies on the registry are indexed under Adenocarcinoma of Lung; 78 are open to participants now.
This study's planned enrollment of 277 is above the median of 63 across 212 interventional studies indexed under Adenocarcinoma of Lung.
Browse Adenocarcinoma of Lung studies →Fudan University is the lead sponsor of 1,270 studies on the registry; 623 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Segmentectomy is performed for solid-dominant invasive lung cancer with size of 2-3cm.
Procedure: Segmentectomy
The lungs are divided into multiple lobes. A segmentectomy involves the removal of part of one of the lobes of the lung to entirely remove a cancerous tumor. segmentectomy can preserve more normal functional lung tissues.
Also known as: Segment resection
5-year disease-free survival
The event is defined as the tumor recurrence or the death due to any causes.
Time frame: 5 years
Lung function test
FEV1/FVC ratio
Time frame: Half year and one year after surgical resection
5-year overall survival
The event is defined as death due to any causes or last follow-up.
Time frame: 5 years
The site of tumor recurrence and metastasis
Outpatient follow-up was conducted regularly after surgery, and the recurrence or metastasis site and time will be recorded.
Time frame: From date of surgery to the last follow-up or date of death from any cause, whichever came first, assessed up to 5 years.
Segmentectomy completion rate
Proportion of patients who complete planned segmentectomy.
Time frame: From the beginning of the surgery to the end of the surgery.
Radical segmentectomy (R0 resection) completion rate
According to the postoperative pathology report of the patients, the proportion of patients with no residual tumor after radical segmentectomy accounted for all patients who underwent segmentectomy.
Time frame: From surgery to the release of the final pathology report, an average of two weeks.
Surgery-related complications
such as air leak, atrial fibrillation, intraoperative or postoperative hemorrhage, postoperative infection, bronchopleural fistula, etc
Time frame: From surgery to patient discharge or 30 days after surgery.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Fudan University